Cyclica is pioneering AI-driven polypharmacology and drug discovery, leveraging machine learning to predict drug-target interactions, off-target effects, and molecular properties. The platform's algorithms analyze chemical libraries, optimize compound selection, and support multi-target drug design for complex diseases. Cyclica partners with pharmaceutical companies, biotech startups, and academic researchers, advancing projects in oncology, neurology, and rare diseases. With robust data integration, cloud-based analytics, and a focus on translational research, Cyclica is shaping the future of multi-target drug development. SEO keywords: "Cyclica AI drug discovery," "AI polypharmacology platform," "multi-target drug design," "AI compound optimization," "Cyclica innovation."